Альфа-пвп: описание и особенности

The 'Causeway Cannibal' case was initially linked to bath salts but later forensic evidence did not definitively confirm this link. It is a molecular analogue of pyrovalerone and structurally related to MDPV (methylenedioxypyrovalerone).

Clinical manifestations of intoxication often include tachycardia (observed in 92% of cases in one study), hypertension, and hyperthermia. Alpha-PVP is typically found in the form of crystals or capsules.

The drug was illegal in only a handful of US states prior to the temporary nationwide ban in 2014. Structural modifications, such as expanding the pyrrolidine ring to piperidine, significantly reduce potency at dopamine transporters.

Forensic analysis often uses LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry) to detect Alpha-PVP in biological samples.

Alpha-PVP is considered a parent compound or closely related to MDPV in structural lineage within the cathinone class. Conformational restriction of the structure (e.g., in aminotetralone derivatives) leads to lower efficacy compared to Alpha-PVP.

Research suggests Alpha-PVP may impair spatial learning and memory through brain mitochondrial dysfunction in animal models. Visual appearance often includes small white or bluish translucent crystals with a shiny surface.

Alpha-PVP (alpha-pyrrolidinovalerophenone) is a synthetic cathinone stimulant. Common street names for Alpha-PVP include 'flakka', 'gravel', and 'niff'.

Oral administration results in effects appearing around 15 minutes post-ingestion and lasting up to 6 hours.

The onset of effects can be subtle or delayed, which may lead to accidental overdosing due to re-dosing. Intranasal administration leads to effects appearing within minutes, lasting approximately 3 hours.

Alpha-PVP imports into New Zealand have been primarily from China and Pakistan since 2012. Its pharmacological effects are likely mediated by the inhibition of dopamine reuptake via the DAT transporter.

It was placed under a temporary nationwide ban in the United States effective February 2014. Strong compulsive desire for re-dosing is a reported characteristic of Alpha-PVP use.

Common clinical symptoms include mydriasis (dilated pupils), diaphoresis (excessive sweating), and seizures.

It is specifically illegal in New South Wales, Australia, following fatal incidents involving users. The substance was marketed as 'legal highs' before being banned in many regions.

The duration of high is approximately 3–5 hours for most routes of administration. Alpha-PVP is not explicitly scheduled under New Zealand's Misuse of Drugs Act but is controlled via structural similarity provisions.

The European Union banned Alpha-PVP in 2015. In New Zealand, it is not explicitly scheduled but treated as a Class C substance due to structural similarity to controlled drugs.

In animal studies, Alpha-PVP has been found to be equally potent and effective as MDPV in terms of reinforcing effects and locomotor stimulation.